Concurrently, the utilization of advanced platforms, such as nanoparticle-based chemiluminescence, enables the real-time analysis of biomarkers
True tachyphylaxis with GLP-1 receptor agonists remains controversial in the clinical literature
High up-front costs According to data from Mercer, prescription drugs represent the fastest growing facet of health benefit costs, with costs per employee rising 7.2% in 2024, due in part to GLP-1s
Can alternate with constipation
PEPTIGRID provides this only as study planning context and does not give human dosing guidance
The panel also discussed that treatment of dermatitis with IL-17 and IL-23 inhibitors, and how technically these treatments may be beneficial for those with lichen planus